Ryan S Cross

5PUBLICATIONS
20CO-AUTHORS
Hybrid and electric vehicles and powertrainsMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Mar 06, 2026
Progress in the development of cytokine armoured CAR T cells.

Krishneel Prasad, Ryan S Cross, Misty R Jenkins

|Aug 07, 2024
EphA3-targeted chimeric antigen receptor T cells are effective in glioma and generate curative memory T cell responses.

Leesa Lertsumitkul, Melinda Iliopoulos, Stacie S Wang

|May 08, 2023
HER2 chimeric antigen receptor T cell immunotherapy is an effective treatment for diffuse intrinsic pontine glioma.

Stacie S Wang, Alexander J Davenport, Melinda Iliopoulos

|Mar 09, 2023
Human EGFRvIII chimeric antigen receptor T cells demonstrate favorable safety profile and curative responses in orthotopic glioblastoma.

Rebecca C Abbott, Melinda Iliopoulos, Katherine A Watson

|May 12, 2021
Novel high-affinity EGFRvIII-specific chimeric antigen receptor T cells effectively eliminate human glioblastoma.

Rebecca C Abbott, Daniel J Verdon, Fiona M Gracey

Pageof 1